Feature

Whole exome sequencing (WES) employs next-generation sequencing technology (NGS), which provides a cost-efficient alternative to WGS. The human whole exome, composed by about 180,000 exons (protein-coding region of the genome) accounts for only 1-2% of the human genome, but up to 85% of the disease-related mutations associated with Mendelian disorders occur in these regions . By targeting these regions, human whole exome sequencing (hWES) provides an in-depth sequencing and analysis approach to indicate genome variants, germline mutations, somatic mutations, and pathogenic mechanisms. hWES service supports a broad range of studies for researchers, including genetic disease-related variants, complex diseases, cancer research, or human population genetics.

Spec : Sequencing and Data

Genomic DNA  Amount: ≧ 500 ng (Qubit)

  • Concentration: ≧ 25 ng/μl
  • Volume:≧ 20μl
  • OD260/280 ≧ 1.8 (NanoDrop)
  • no degradation, no
    contamination

Sequencing Spec

  • Model and Mode: Novaseq 6000 / X Plus, PE 150
  • Library kits:Agilent, IDT or Roche/KAPA
  • Output Data: 6G, IDT or 8G, Roche/KAPA

Data and bioinformatics

  • Data Delivery:fastq or Data quality control /Alignment to a reference genome/ SNP and InDel calling